Pursuant to the Regulation 30 of the SEBI (Listing Obligation & Disclosure Requirements) Regulations, 2015, Astrazeneca Pharma India has informed about meetings with investors/analysts is scheduled to be held at Corporate office, Bangalore on 23rd & 24th July 2019.
The above information is a part of company’s filings submitted to BSE.